Monday, 14 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
CStone Pharmaceuticals’ Sugemalimab Wins UK Approval for NSCLC Treatment
October 31, 2024
Company
Dizal Pharmaceutical’s Q3 2024 Revenues Soar 236% YOY on Strong Product Sales
October 31, 2024
Company
Amgen Reports Q3 2024 Revenues of USD 8.5 Billion, Marking a 23% YOY Increase
October 31, 2024
Company
Deals
HOB Biotech Group and Sino Biopharmaceutical Ltd Form Strategic Partnership in Allergy Treatments
October 31, 2024
Company
Sandoz Q3 2024 Sales Boosted by Biosimilars and Generics, Up 12% YOY
October 31, 2024
Company
Junshi Biosciences Reports Q3 2024 Financials with Revenue Growth and Narrowed Losses
October 31, 2024
Company
Deals
Chipsscreen Biosciences and Zhejiang Hisun Pharmaceutical End Strategic Partnership for Chiglitazar Launch
October 31, 2024
Company
Eli Lilly Reports 20% YOY Revenue Growth in Q3 2024 Driven by Mounjaro and Zepbound
October 31, 2024
Company
AstraZeneca China President Leon Wang Involved in Chinese Investigation Amid Industry Probes
November 3, 2024
Company
Drug
AbbVie’s Allergan Aesthetics Launches Juvéderm VOLUX in China
October 31, 2024
Company
Deals
Jiangsu Yuyue Medical Equipment Partners with TÜV SUD to Boost Medical Device Market Access
December 26, 2024
Company
GSK Reports Mixed Q3 2024 Results with 2% YOY Revenue Growth
October 31, 2024
1
2
3
…
24
25
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
